N/A

The present invention is a "method of producing a micro dose of potentized culture of Mycobacterium Tuberculosis for the treatment of various ailments" in which:- An adequate quantity of a virulent strain of Mycobacterium tuberculosis (M.T.) extracted from the sputum of a Pulmonary Tuberculosis patient is mixed w...

The present disclosure relates to the field of homeopathy based formulation. The homeopathy based formulation of the present disclosure comprises at least one serially diluted and potentized cancer nosode and a vehicle. Typically, the ratio of the cancer nosode to the vehicle is in the range of 1:9 for 1C potency an...

The present disclosure provides an anti-inflammatory formulation comprising a homogenized mixture of at least one potentised cytokines selected from the group consisting of IL la (interleukin 1-alpha), IL lb (interleukin 1-beta), IL 2, IL 4, IL 5, IL 6, TNF-a (Tumor Necrosis Factor-alpha), INF-y, IL 12, IL 13, IL 17...

The present invention provides an improved method for preparation of nosodes, which takes advantage of the advancements in microbiology, immunology and cellular biology, to standardize the therapeutic source material for nosodes, while enhancing the potency of nosodes, produced thereof. Further, the method provides:...

A formulation comprising a potentized mixture of an extract of capsaicin and an extract of dihydrocapsaicin in a ratio of about 50 : 1 to about 1 : 50 in a solvent where the ratio of combined extract to solvent ranges from about 0.5 to 100 to about 2 :100 .

A formulation for the treatment of autoimmune diseases is disclosed. The formulation comprising a homogenized mixture of at least one serially diluted and potentised ingredient selected from a group consisting of TNF- alpha, IFN- y, IL-8, IL17, IL-20, IL 23 and STAT 3, said dilution being effected in a vehicl...

A composition for the treatment of infection (RTI) comprising, a homogenized mixture of at least two serially diluated and potentized substance, as herein described, selected from; 1.Mycobacterium tuberculosis (culture) (strain A) 2. Mycobacterium bovis (culture) (strain B) 3. Mycobacterium microti (culture) (strain...

A novel medicinal formulation for the treatment of autoimmune diseases, said formulation comprising, combined serially diluted and potentized HIV TYPE I virus and HIV TYPE II virus, said dilution effected in a vehicle selected from a group consisting of distilled water or ethyl alcohol and mixture of distilled water...

A formulation comprising a potentized mixture of triturated Lichen planus tissue with histamine in the ratio of about 1:2 to about 2:1 in a vehicle, where the ratio of the mixture to the vehicle , can be varied from 1:99 to 50:50.

A composition for the treatment of Hepatitis C is disclosed. The composition comprises a homogenized mixture of at least one serially diluted and potentized substance, as herein described, selected from: Hepatitis C Genotype 1, Hepatitis C Genotype 2, Hepatitis C Genotype 3, Hepatitis C Genotype 4, Hepatitis C Genot...

ABSTRACT PHARMACEUTICAL COMPOSITION The present disclosure relates to a pharmaceutical composition comprising potentized mixture of at least two compounds selected from Hydrogen peroxide; Nle4,DPhe7-a-melanocyte-stimulating hormone, Kojic acid, and 6-biopterin. The present disclosure further relates to a process ...

The present disclosure relates to a homeopathy based formulation. The homeopathy based formulation comprises at least one potentized mixture of malaria nosode, and a vehicle. The malaria nosode can be obtained from at least one malaria parasite selected from the group consisting of Plasmodium falciparum, Plasmodium ...

The present disclosure relates to a polynosodic homeopathic composition comprising a homogenized mixture of a potentized polynosode and a vehicle. The polynosode is obtained from virulent strains of a plurality of pathogens selected from the group consisting of Escherichia coli, Salmonella typhi, Klebsiella pneumoni...

ABSTRACT NOSODES FOR PREVENTON, ALLEVIATION OF SYMPTOMS AND TREATMENT OF VIRAL INFECTIONS The present disclosure relates to the field of homeopathic formulations, particularly to a nosode composition for prevention, alleviation of symptoms and treatment of viral infections such as Coronavirus disease 2019 (Covid-1...